Kimberly Smith

Apretude

Pharma

GSK feeds HIV PrEP drug to patent pool amid US launch

GSK's ViiV licenses its long-acting HIV prevention drug Apretude to the Medicines Patent Pool just seven months after an FDA approval.

Angus Liu Jul 28, 2022 10:00am

topic report

Influential scientists

Most influential people in biopharma—the scientists

May 9, 2022 3:00am